Lv3
300 积分 2023-09-04 加入
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
1天前
已完结
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
1天前
已完结
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
13天前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
27天前
已完结
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
1个月前
已完结
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study
1个月前
已完结
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
1个月前
已完结
Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology
1个月前
已完结
Clinical pharmacology of CAR-T cells: Linking cellular pharmacodynamics to pharmacokinetics and antitumor effects
1个月前
已完结
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective
1个月前
已完结
皖公网安备34019202002308
